DCIS 411

DCIS News Articles

We are committed to sharing the latest news, research, and media coverage surrounding ductal carcinoma in situ (DCIS) and the growing movement toward informed, individualized care. This page features recent articles highlighting active monitoring for low-risk DCIS, personalized risk assessment tools, concerns about overdiagnosis and overtreatment, and the ongoing discussion about removing the misleading term “carcinoma” from DCIS terminology.

We believe women deserve access to balanced information that reflects evolving science and supports thoughtful decision-making rather than fear-based treatment approaches. You will also find interviews, videos, and media appearances featuring DCIS 411 Founder Donna Pinto, who has spent many years advocating for patient education, informed consent, and greater awareness of the controversies surrounding DCIS diagnosis and treatment.

Below are recent news articles highlighting the growing support for active monitoring for DCIS, personalized risk assessment, and the debate around changing the name to remove the misleading term “carcinoma.”

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are ‘reassuring’, Medical Xpress, March 26, 2026

LESS IS MORE : Thousands of women with breast cancer could soon be told they don’t need ANY treatment at all, The Sun, 26 Mar 2026

Lauded Study Finds Surgery May Not Be Necessary for Precancerous Breast Condition, USA TODAY,  March 25, 2026

Rates of Bilateral Mastectomy Have Doubled in Low-Risk HR+ Ductal Carcinoma In Situ, Cancer Therapy Advisor, Feb 17, 2026

What to Know Before Saying Yes to Routine Screenings: Screening can catch disease early–or turn healthy people into patients. EPOCH HEALTH, January 07, 2026

For DCIS: Surveillance or Surgery? Experts Debate Merits and Shortcomings of Both Approaches, General Surgery News, Jan 6, 2026

Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ, ESMO, 08 Jan 2025

Is Active Monitoring a Safe Option for Patients With Ductal Carcinoma In Situ?, The ASCO Post, May 10, 2025

Should We Still Call It Cancer? The Weight of a Word, Medscape, December 11, 2025

Reframing DCIS as an Opportunity for Cancer Prevention, The American Society of Clinical Oncology (ASCO) Post, March 10, 2024

Over many years, DCIS 411 Founder Donna Pinto has been interviewed in the media. Please take time to watch videos and read articles featuring Donna & DCIS in the Media

 

Support Us!

DCIS 411 is a nonprofit public service website.

Your donation fuels a mission grounded in research and aligned with the latest scientific understanding of DCIS. As double mastectomy rates for DCIS continue to rise, our work is more urgent than ever. We drive awareness and advocacy that empowers women to make informed, confident breast health decisions. We share evidence-based resources on safer, non-toxic imaging options and connect women with integrative doctors, nutritionists, and advocates who prioritize healing, balance, and informed consent. Your generosity also helps provide financial assistance for safer screening and holistic care for those who need it most. 
 
Join us in advancing the future of breast health that is free from fear, profit, or pressure.
 
Give Wellness, founded in 2016 by Donna Pinto, is fiscally sponsored by Social Good Fund, a 501(c)(3) nonprofit organization (EIN: 46-1323531). All donations are tax-deductible.
 
 “Alone we can do so little — together we can do so much.” — Helen Keller

Leave a Reply